Continuous granulation and compression line for pharmaceuticals

In pharmaceutical manufacturing, continuous processes streamline production while ensuring product quality and consistency. Traditional batch processes can face challenges like variability in granule properties, high work-in-progress inventory, and complex scale-up scenarios.

Integrate granulation, drying, and compression

The ConsiGma® GC lines by GEA integrate continuous wet granulation, fluid bed drying, and tablet compression into one efficient continuous production system. Designed to enhance supply chain agility and reduce the manufacturing footprint, these lines feature controlled granulation for better distribution of the binder and precise porosity control of granules. Available in three sizes, the system accommodates throughput from 5 to 120 kg/h or 20,000 to 180,000 tablets/h, tailored to customer needs. The Conductor 4.0 software ensures comprehensive control, full reporting, and track & trace capabilities. Ideal for high-value products, orphan drugs, and new chemical entities, optional features include advanced dosing, blending units, and containment upgrades for handling potent formulations.

Benefits

  • Controlled granulation ensures consistent quality
  • Efficient use of API reduces wastage
  • Flexible throughput capacities
  • Seamless integration of critical processes
  • Small production footprint